Outset Medical to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) will release its financial results for Q4 and the full year of 2020 on March 9, 2021, after market close. A conference call led by CEO Leslie Trigg and CFO Rebecca Chambers will discuss financial and operating results at 2:00 PM PT (5:00 PM ET). Investors can participate via phone or listen to a live and archived webcast on Outset's website. Outset is recognized for its Tablo Hemodialysis System, designed to streamline dialysis care and facilitate treatment at home or in clinics.

Positive

• Outset is set to release Q4 and full-year 2020 financial results, potentially indicating positive business performance.
• The Tablo Hemodialysis System is a significant innovation in dialysis care, enhancing patient experience and operational efficiency.

Negative

• None.

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2020 after the close of trading on Tuesday, March 9, 2021.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Rebecca Chambers, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, March 9, 2021. Interested parties may access the live teleconference by dialing (833) 614-1409 for domestic callers or (914) 987-7130 for international callers, followed by conference ID: 8495745. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005980/en/

FAQ

When will Outset Medical release its Q4 2020 financial results?

Outset Medical will release its Q4 2020 financial results on March 9, 2021.

What time is the Outset Medical conference call?

The conference call will take place at 2:00 PM Pacific Time (5:00 PM Eastern Time) on March 9, 2021.

How can I access the Outset Medical conference call?

You can access the conference call by dialing (833) 614-1409 for domestic calls or (914) 987-7130 for international calls, using conference ID: 8495745.

What is the Tablo Hemodialysis System?

The Tablo Hemodialysis System is a pioneering technology by Outset Medical designed to simplify and reduce the cost of dialysis, allowing treatment to be administered anywhere.